[1]杨雪,时立新,张巧,等.中老年人群25-羟维生素D3与代谢综合征的 相关性分析[J].国际内分泌代谢杂志,2014,(05):289-294.[doi:10.3760/cma.j.issn.1673-4157.2014.05.001]
　Yang Xue*,Shi Lixin,Zhang Qiao,et al.Association between 25-hydroxyvitamin D3 and metabolic syndrome in middle-aged and elderly population[J].International Journal of Endocrinology and Metabolism,2014,(05):289-294.[doi:10.3760/cma.j.issn.1673-4157.2014.05.001]
点击复制

中老年人群25-羟维生素D3与代谢综合征的 相关性分析()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
期数:
2014年05期
页码:
289-294
栏目:
论著
出版日期:
2014-10-31

文章信息/Info

Title:
Association between 25-hydroxyvitamin D3 and metabolic syndrome in middle-aged and elderly population
作者:
杨雪; 时立新; 张巧; 彭年春; 吴丹荣
558000 贵阳医学院第三附属医院内分泌科(杨雪); 550004 贵阳医学院附属医院内分泌科(时立新,张巧,彭年春,吴丹荣)
Author(s):
Yang Xue*; Shi Lixin;  Zhang Qiao;  Peng Nianchun;  Wu Danrong.
*Department of Endocrinology, The Third Affiliated Hospital of Guiyang Medical University, Guiyang 558000,China Corresponding author: Shi Lixin, Email:slx1962@medmail.com.cn
关键词:
25-羟维生素D3;  代谢综合征;  中老年人
Keywords:
25-Hydroxyvitamin D3;  Metabolic syndrome;  Middle-aged and elderly people
DOI:
10.3760/cma.j.issn.1673-4157.2014.05.001
摘要:
目的 研究中老年人群25-羟维生素D3[25(OH)D3]与代谢综合征(MS)及其各组分的关系。方法 采用整群随机抽样方法选取贵阳市宅吉小区50～70岁,且在本社区居住10年以上人群463名,男性190名,女性273名。所有研究对象进行问卷调查,测量身高、体重、腰围、血压等相关指标,抽血测血糖、血脂、空腹胰岛素、25(OH)D3浓度等指标。MS的诊断采用国际糖尿病联盟标准。结果(1)血清25(OH)D3水平为(21.98±8.32)ng/ml,MS的患病率为38.9%, MS在25(OH)D3异常及正常组人群的患病率依次为82.8%、26.6%(P均<0.05)。(2)25(OH)D3正常组男性比例、教育程度、钙剂补充高于25(OH)D3异常组; 腰围、空腹血糖、口服葡萄糖耐量试验2 h血糖、甘油三酯及稳态模型评估-胰岛素抵抗指数(HOMA-IR)低于25(OH)D3异常组(P<0.05)。(3)25(OH)D3水平与MS的发生呈负相关[β=-0.667,优势比(OR)=0.513,P<0.05]; 与腰围、空腹血糖、甘油三酯、HOMA-IR呈负相关(P<0.05)。结论 中老年人群低25(OH)D3水平更易发生MS,低25(OH)D3水平可能增加MS及其各组分的患病风险。
Abstract:
Objective To evaluate the association between 25-hydroxyvitamin D3[25(OH)D3] and metabolic syndrome(MS)as well as the components of MS in middle-aged and elderly population. Methods A total of 463 individuals(190 male cases and 273 female cases )aged 50-70 years with more than 10 years of residence in Zhaiji community of Guiyang city were recruited by cluster random sampling method.A standard questionnaires,anthropometric parameters, blood lipids,blood glucose,fasting insulin, plasma 25(OH)D3 concentration were tested. MS was diagnosed according to the International Diabetes Federation(IDF)criteria. Results(1)The mean 25(OH)D3 concentration was(21.98±8.32)ng/ml. Prevalence of MS was 38.9%.In 25(OH)D3 deficiency,insufficiency,and sufficiency group, the prevalence of MS were 82.8%,and 26.6%(P<0.05).(2)Compared with 25(OH)D3 abnormal group, the male percentage, education and calcium supplement in 25(OH)D3 sufficiency group were higher(P<0.05)and waist circumference,fasting plasma glucose,oral glucose tolerance test 2 hours glucose,triglyceride,homeostasis model of assessment for insulin resistance index(HOMA-IR)was lower(P<0.05).(3)An inverse associations existed between 25(OH)D3 levels and MS prevalence [β=-0.667,odd ratio(OR)=0.513, P<0.05]. Plasma 25(OH)D3 concentration was significantly and negatively associatied with waist circumference, fasting plasma glucose,triglyceride and HOMA-IR(P<0.05). Conclusions Middle-aged and elderly people with lower 25(OH)D3 level has higher MS prevalence. A low 25(OH)D3 level may increase the risk of MS and components of MS.

参考文献/References:

[1] Feldman D, Pike JW, Glorieux FH,eds. Vitamin D[M〗. San Diego: Elsevier Academic Press, 2005:1982.
[2] Judd SE, Tangpricha V. Vitamin D deficiency and risk for cardiovascular disease[J].Am J Med Sci, 2009,338(1):40-44.
[3] Lu L, Yu Z, Pan A, et al. Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals[J].Diabetes Care, 2009,32(7):1278-1283.
[4] Majumdar V, Nagaraja D, Christopher R.Vitamin D status and metabolic syndrome in Asian Indians[J].Int J Obes, 2011,35(8):1131-1134.
[5] Holick M F. Vitamin D deficiency[J].N Engl J Med, 2007,357(19):266-281.
[6] 中国肥胖问题工作组数据汇总分析协作组[J].中华流行病学杂志, 2002,23(1):5-10.
[7] Alberti KG, Zimmet P, Shaw J. The metabolic syndrome--a new worldwide definition[J].Lancet, 2005,366(9491):1059-1062.
[8] Rosen CJ. Clinical practice. Vitamin D insufficiency[J].N Engl J Med, 2011,364(3):248-254.
[9] Bouillon R, Okamura WH, Norman AW. Structure-function relationships in the vitamin D endocrine system[J].Endocr Rev, 1995,16(2):200-257.
[10] Townsend K, Evans KN, Campbell MJ, et al. Biological actions of extra-renal 25-hydroxyvitamin D-1alpha-hydroxylase and implications for chemoprevention and treatment[J].J Steroid Biochem Mol Biol, 2005,97(1/2):103-109.
[11] Reis JP, von Mühlen D, Miller ER. Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults[J].Eur J Endocrinol, 2008,159(1):41-48.
[12] Hypponen E, Boucher BJ, Berry D J, et al. 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age[J].Diabetes, 2008,57(2):298-305.
[13] 林寰东,高键,马慧,等. 中老年人群25-羟维生素D与代谢综合征关系的研究[J].中华内分泌代谢杂志, 2013,29(10):840-845.
[14] Maestro B, Campión J, Dávila N, et al. Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells[J].Endocr J, 2000,47(4):383-391.
[15] Pittas AG, Lau J, Hu FB, et al. The role of vitamin D and Calcium in type 2 diabetes. A systematic review and meta-analysis[J].J Clin Endocrinol Metab, 2007,92(6):2017-2029.
[16] Scragg R, Sowers M, Bell C, et al.Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey[J].Diabetes Care, 2004,27(12):2813-2818.
[17] Tzotzas T, Papadopoulou FG, Tziomalos K, et al. Rising serum 25-hydroxy-vitamin D levels after weight loss in obese women correlate with improvement in insulin resistance[J].J Clin Endocrinol Metab, 2010,95(9):4251-4257.
[18] Osei K. 25-OH vitamin D: is it the Universal panacea for metabolic syndrome and type 2 diabetes?[J].J Clin Endocrinol Metab, 2010,95(9):4220-4222.
[19] Zhou QG, Hou FF, Guo ZJ, et al. 1,25-Dihydroxyvitamin D improved the free fatty-acid-induced insulin resistance in cultured C2C12 cells[J].Diabetes Metab Res Rev, 2008,24(6):459-464.
[20] Li YC, Kong J, Wei M, et al. 1,25-Dihydroxyvitamin D(3)is a negative endocrine regulator of the renin-angiotensin system[J].J Clin Invest, 2002,110(2):229-238.
[21] Forman JP, Giovannucci E, Holmes MD, et al. Plasma 25-hydroxy- vitamin D levels and risk of incident hypertension[J].Hypertension, 2007,49(5):1063-1069.

相似文献/References:

[1]曹琳,杨昱,刘超.减重手术对多囊卵巢综合征的治疗作用[J].国际内分泌代谢杂志,2014,(06):415.[doi:10.3760/cma.j.issn.1673-4157.2014.06.015]
　Cao Lin,Yang Yu,Liu Chao..Therapeutic effects of bariatric surgery on polycystic ovary syndrome[J].International Journal of Endocrinology and Metabolism,2014,(05):415.[doi:10.3760/cma.j.issn.1673-4157.2014.06.015]
[2]梁绮君 余寿益 李淑华 胡晨鸣 杨焱.甲状腺结节与代谢综合征的相关性研究[J].国际内分泌代谢杂志,2015,(05):293.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.002]
　Liang Qijun,Yu Shouyi,Li Shuhua,et al.Association of thyroid nodule and metabolic syndrome[J].International Journal of Endocrinology and Metabolism,2015,(05):293.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.002]
[3]王姝洁,张翼飞,张志国.雷公藤红素在治疗代谢综合征中的作用及相关机制[J].国际内分泌代谢杂志,2017,37(04):258.
　Wang Shujie,Zhang Yifei,Zhang Zhiguo..Effects and related mechanisms of celastrol in the treatment of metabolic syndrome[J].International Journal of Endocrinology and Metabolism,2017,37(05):258.
[4]王雪姣,丁晓颖,彭永德.短链脂肪酸在2型糖尿病发病机制中的作用[J].国际内分泌代谢杂志,2017,37(04):270.
　Wang Xuejiao,Ding Xiaoying,Peng Yongde..The role of short chain fatty acids in the pathogenesis of type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2017,37(05):270.
[5]高璐,信中,袁明霞,等.代谢综合征与糖尿病及糖尿病前期人群 糖尿病视网膜病变的相关性分析[J].国际内分泌代谢杂志,2017,37(05):298.
　Gao Lu*,Xin Zhong,Yuan Mingxia,et al.A study on correlation between metabolic syndrome and diabetic retinopathy in diabetic and pre-diabetic people[J].International Journal of Endocrinology and Metabolism,2017,37(05):298.
[6]谢幸 陈树春 朱海娇 刘阳 王幸.蛙皮素样受体亚型-3与代谢综合征[J].国际内分泌代谢杂志,2018,38(03):176.[doi:10.3760/cma.j.issn.1673-4157.2018.03.008]
　Xie Xing*,Chen Shuchun,Zhu Haijiao,et al.Bombesin receptor subtype-3 and metabolic syndrome[J].International Journal of Endocrinology and Metabolism,2018,38(05):176.[doi:10.3760/cma.j.issn.1673-4157.2018.03.008]
[7]聂秀玲.长期果糖摄入与代谢综合征[J].国际内分泌代谢杂志,2018,38(05):339.[doi:10.3760/cma.j.issn.1673-4157.2018.05.014]
　Nie Xiuling.Chronic fructose intake and metabolic syndrome[J].International Journal of Endocrinology and Metabolism,2018,38(05):339.[doi:10.3760/cma.j.issn.1673-4157.2018.05.014]
[8]肖扬 徐书杭 黄华英 郭玲 吕文君 冯宁霞 汪奇峰 茅晓东 陈国芳 刘超.常州地区青少年人群不同代谢综合征诊断标准的比较研究[J].国际内分泌代谢杂志,2020,40(01):1.[doi:10.3760/cma.j.issn.1673-4157.2020.01.001]
　Xiao Yang,Xu Shuhang,Huang Huaying,et al.A comparative study of the different diagnostic criteria for metabolic syndrome among adolescents in Changzhou area[J].International Journal of Endocrinology and Metabolism,2020,40(05):1.[doi:10.3760/cma.j.issn.1673-4157.2020.01.001]
[9]王应昉 曹璐 陈凤 许帅 陈风 郭妍 王岩 王涤非.社区老年居民握力体重指数与代谢综合征的相关性[J].国际内分泌代谢杂志,2020,40(01):5.[doi:10.3760/cma.j.issn.1673-4157.2020.01.002]
　Wang Yingfang,Cao Lu,Chen Feng,et al.Relationship between handgrip strength body mass index and metabolic syndrome in community elderly residents[J].International Journal of Endocrinology and Metabolism,2020,40(05):5.[doi:10.3760/cma.j.issn.1673-4157.2020.01.002]
[10]权海侠 闫妮.每日膳食钾摄入量与代谢综合征的相关性[J].国际内分泌代谢杂志,2020,40(03):154.[doi:10.3760/cma.j.issn.1673-4157.2020.03.003]
　Quan Haixia,Yan Ni.Correlation between daily dietary potassium intake and metabolic syndrome[J].International Journal of Endocrinology and Metabolism,2020,40(05):154.[doi:10.3760/cma.j.issn.1673-4157.2020.03.003]

备注/Memo

备注/Memo:
基金项目:贵州省优秀科技教育人才省长专项资金项目[黔省专合字(2010)82号]; 贵州省科技厅贵阳医学院社发联合基金[黔科合(2010)3148] 通信作者:时立新,Email:slx1962@medmail.com.cn
更新日期/Last Update: 2014-09-20